These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9420819

  • 1. Biokinetics and dosimetry analysis in healthy volunteers for a two-injection (rest-stress) protocol of the myocardial perfusion imaging agent technetium 99m-labeled Q3.
    Rohe RC, Thomas SR, Stabin MG, Deutsch EA, Gerson MC, Cummings DD, Maxon HR.
    J Nucl Cardiol; 1995; 2(5):395-404. PubMed ID: 9420819
    [Abstract] [Full Text] [Related]

  • 2. [A comparison between 99mTc-Q3 and 201Tl on clearance and retention properties at varying coronary flow rates in isolated rabbit heart].
    Fan C, Tan T, Li Y, Kuang A, Liang Z, Chen Y.
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):225-8, 231. PubMed ID: 12600092
    [Abstract] [Full Text] [Related]

  • 3. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
    Kemerink GJ, Boersma HH, Thimister PW, Hofstra L, Liem IH, Pakbiers MT, Janssen D, Reutelingsperger CP, Heidendal GA.
    Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
    [Abstract] [Full Text] [Related]

  • 4. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.
    Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A.
    J Nucl Med; 1993 Jan; 34(1):30-8. PubMed ID: 8418268
    [Abstract] [Full Text] [Related]

  • 5. Biodistribution, dosimetry, and safety of myocardial perfusion imaging agent 99mTcN-NOET in healthy volunteers.
    Vanzetto G, Fagret D, Pasqualini R, Mathieu JP, Chossat F, Machecourt J.
    J Nucl Med; 2000 Jan; 41(1):141-8. PubMed ID: 10647617
    [Abstract] [Full Text] [Related]

  • 6. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
    McGoron AJ, Biniakiewicz D, Millard RW, Kumar A, Kennedy SC, Roszell NJ, Gabel M, Huth C, Walsh RA, Gerson MC.
    Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
    [Abstract] [Full Text] [Related]

  • 7. Cardiac stress-rest single-photon emission computed tomography with technetium 99m-labeled tetrofosmin: influence of washout kinetics on regional myocardial uptake values of the rest study with a 1-day protocol.
    Schulz G, Ostwald E, Kaiser HJ, vom Dahl J, Kleinhans E, Buell U.
    J Nucl Cardiol; 1997 Nov; 4(4):298-301. PubMed ID: 9278876
    [Abstract] [Full Text] [Related]

  • 8. [Safety, biodistribution, and dosimetry of myocardial imaging agent 99Tc(m)N-NOET in healthy volunteers].
    Du YR, Li F, Wang XB, Tang ZG, Tian J, Ba JT, Long MQ, Zhang JB.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):517-21. PubMed ID: 19209797
    [Abstract] [Full Text] [Related]

  • 9. Influence of patient height and weight and type of stress on myocardial count density during SPECT imaging with thallium-201 and technetium 99m-sestamibi.
    O'Connor MK, Bothun E, Gibbons RJ.
    J Nucl Cardiol; 1998 Aug; 5(3):304-12. PubMed ID: 9669585
    [Abstract] [Full Text] [Related]

  • 10. Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection.
    Manka-Waluch A, Palmedo H, Reinhardt MJ, Joe AY, Manka C, Guhlke S, Biersack HJ, Bucerius J.
    Ann Nucl Med; 2006 Dec; 20(10):663-70. PubMed ID: 17385304
    [Abstract] [Full Text] [Related]

  • 11. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G, Neverve J, Matsunari I, Schröter G, Schwaiger M.
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [Abstract] [Full Text] [Related]

  • 12. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K, Riou LM, Ruiz M, Yamamichi Y, Duatti A, Lima RL, Goode AR, Watson DD, Beller GA, Glover DK.
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Whole-body biodistribution and radiation dosimetry of the new cardiac tracer 99mTc-N-DBODC.
    Cittanti C, Uccelli L, Pasquali M, Boschi A, Flammia C, Bagatin E, Casali M, Stabin MG, Feggi L, Giganti M, Duatti A.
    J Nucl Med; 2008 Aug; 49(8):1299-304. PubMed ID: 18632816
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Preclinical pharmacological study of a novel myocardial perfusion agent: 99mTc-Q3].
    Fan C, Tan T, Li Y, Kuang A, Liang Z, Chen Y.
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Mar; 31(1):11-3. PubMed ID: 12501600
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection.
    Gremillet E, Champailler A.
    Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.